Carnegie acted as financial advisor to SpinChip Diagnostics ASA and its owners in the sale to bioMérieux.
SpinChip Diagnostics is a pioneering diagnostics company developing next-generation point-of-care platforms for in vitro diagnostics.
bioMérieux is a world leader in the field of in vitro diagnostics.